For organisations
Sustained performance depends on two things an organisation can shape: the way work is designed, and the health and wellness system around it. Basilia Health helps organisations understand where capacity is being lost, decide what to change, design a more coherent system and measure what happens next.
This is physician-led, evidence-led work. Individual clinical information stays within the clinician–patient relationship; the organisation receives agreed operational information and carefully controlled aggregate reporting only.
Physician-led · Privacy-bounded
Why it matters
The people an organisation relies on carry sustained cognitive, emotional and physical load. Capacity is reduced both by how work is designed — workload, meeting load, travel, after-hours expectations and too little recovery — and by a health and wellness system that is fragmented, poorly used or not built on evidence. The two interact, and each is often recognised late or managed in pieces.
Generic wellness activity rarely identifies either problem. Neither does an annual medical that produces results without interpretation, prioritisation or follow-through.
What remains unmeasured is easily normalised.
Two questions
Organisational health work often fails because it answers the wrong question. Basilia separates two questions that are usually run together — one about the work system, one about the health and wellness system — because the right diagnostic depends on which one you are asking.
Is the way the organisation operates reducing people's capacity to perform sustainably?
This leads to
It examines the work system — for example:
It is an organisational, system-level diagnostic. It is not:
Is our health and wellness system coherent, evidence-supported and useful — and is the organisation helping or undermining it?
This leads to
It may examine:
It may examine organisational conditions only where they materially affect the health and wellness programme. It is not a full diagnosis of:
If deeper work-system issues appear material, Basilia recommends a separate Organisational Capacity Review rather than stretching the audit beyond what it can properly assess.
These two systems are related, but they are not the same. Basilia keeps the diagnostics distinct so each question is answered properly, and does not present one as a substitute for the other.
Whole workforce
The Health & Wellness Programme Audit & Strategy looks at the agreed health and wellness system across the workforce, not only at senior people. The workforce-wide system is the organising architecture.
Where it is justified, the programme may then include differentiated pathways for priority populations, such as:
This does not mean every organisation needs an executive pathway. Differentiated pathways are added only where the evidence and the organisation's needs justify them; the whole-workforce system remains the foundation.
Measurement
Measurement is designed in from the start: define the intended outcome, establish appropriate baseline information where possible, distinguish process measures from outcome measures, and re-measure to see what actually changed. Programme-level measurement is reported in aggregate under privacy safeguards.
It cannot establish that a change caused a business outcome. Selection, baseline differences, missing data and small groups all limit interpretation. Basilia does not promise reduced absenteeism, increased productivity, improved profit or a return on investment, and states the causal limits of any measure honestly.
Where external evidence is discussed, its population and measurement limits are stated and it is not presented as a Basilia result.
Basilia's organisational measurement methods, including the Basilia Organisational Capacity Index, are still being developed. Basilia does not present the Capacity Index as validated, and does not claim validated thresholds, benchmarks, predictive validity or certification. No composite measure is presented as validated or predictive.
Ongoing relationships
After the diagnostics, some organisations want continuing input. These are described in order of depth, not as equal products to choose between — most engagements begin with a single diagnostic.
Ongoing access to Basilia's evidence interpretation and bounded strategic health and performance advice. It is not unlimited access, and it does not provide individual clinical care through an employer retainer.
A developing, later-stage capability for organisations with an established programme: ongoing stewardship of evidence, provider quality, pathways, agreed outcomes, measurement and programme-relevant interfaces, with periodic improvement decisions. It is not administrative PMO work, generic HR governance, or a Capacity Review by another name.
The longer-term destination relationship, working through the full cycle — measure, understand, design, improve, govern, re-measure. It is a direction Basilia is building toward, not a fully mature service today.
None of these is generally available yet, and their status is shown so intended scope and readiness are clear before any discussion. Basilia Health is based in Namibia, and organisational engagements are being developed within confirmed clinical and operational capacity. Any future pricing would be determined by scope — participants, depth, delivery and reporting — rather than a published fixed price.
Clinical pathways
Where an organisation sponsors individual clinical assessment for leaders or other critical roles, that is one differentiated pathway inside the broader system — not the whole organisational offer. Where individual clinical care is required, it is delivered through the appropriately licensed clinical provider responsible for that patient's care. Basilia's near-term clinical model is partner-enabled: Basilia leads the programme, and direct Basilia clinical delivery remains a future capability subject to the required infrastructure and governance.
Basilia may develop more of this clinical delivery directly over time. That is a future direction; Basilia does not currently operate its own full executive-health clinical service.
This clinical pathway is in development and is not generally available. The privacy and confidentiality boundaries below apply to it in full.
Roles
Individual clinical information is handled within the clinician–patient relationship, subject to informed consent, professional duties and applicable law. Employers receive only agreed operational information and carefully controlled de-identified aggregate reporting where the required consent, minimum-cohort and disclosure safeguards are met.
Participation in individual clinical assessment and care is voluntary. Declining must not be treated as misconduct, and the organisation does not receive individual clinical results.
Employer information
| Category | Standard reporting position | Conditions |
|---|---|---|
| Contract and implementation status | Yes | Scope, milestones, invoices, programme-level issues |
| Invitation / enrolment counts | Yes, if contracted | Counts only; avoid exposing reasons for non-participation |
| Named scheduling status | Only if necessary | Disclose in advance; restrict to authorised gatekeepers; no clinical status |
| Named completion status | Only if necessary and disclosed | “Completed” must not imply fitness, diagnosis or outcome |
| Individual clinical report | No | Specific express consent or narrow legal/serious-harm basis |
| Diagnosis, medication, laboratory result | No | Do not disclose by default |
| Individual health score or profile | No | Do not disclose by default; a code is not sufficient protection |
| Aggregate outcomes | Yes, when safe | Minimum cohort, cell suppression, de-identification and disclosure review |
| Programme recommendations | Yes | Must not expose individuals; distinguish clinical findings from organisational observations |
| Urgent safety matter | Exceptionally | Clinical lead decision; minimum necessary; legal/professional advice where feasible |
| Fitness / work capacity conclusion | Only under a separate occupational pathway | Specific purpose, consent, scope and reporting standard |
How it works
A clinical engagement is not a fixed programme. The participant journey describes what an individual may experience. The Basilia method describes how information is assessed and acted on clinically. They are related but distinct, and the exact scope would be agreed for each engagement.
Participant journey
Basilia method
Where a finding requires further medical assessment or specialist input, it is communicated and escalated through the participant's clinical care—not reported to the organisation unless the participant specifically authorises disclosure or a narrow legal or serious-harm basis applies.
Trust and confidentiality
Clinical care is accountable to the treating clinician's clinical-governance structure rather than to the sponsoring organisation.
Tests should answer a defined clinical question, have an interpretation pathway and be capable of changing management. Basilia's model favours relevant assessment and diagnostic governance over indiscriminate screening.
Basilia does not rank individuals by health risk, name individuals behind aggregate trends, disclose who declined or screened positive, share raw records, or support the use of clinical data for selection, discipline, remuneration or performance management.
Next step
A first conversation would establish where the organisation thinks capacity is being lost, which of the two diagnostics fits, what reporting would and would not include, and whether the privacy boundaries are acceptable to all parties.
Organisational enquiries will open in a later phase.
When enquiries open, please do not send clinical or personal health information through the website.